Skip to main content
. 2022 Jun 26;14(13):2647. doi: 10.3390/nu14132647

Table 2.

Collected studies of pure compounds suggesting neuroprotective activity of hesperidin and hesperetin.

Hesperidin
Model Observations/proposed mechanism Reference
Human neuroblastoma SK-N-SH cells
  • -

    Maintenance of mitochondrial membrane potential

  • -

    Antioxidant—increase in glutathione, SOD, GSH-Px levels

  • -

    Antiapoptotic—downregulation of Bax, caspase-3, 9; upregulation of Bcl-2

[58]
Neuro-2A cells
  • -

    Inhibition of β-amyloid-induced autophagy

  • -

    Improved glucose utilization

[59]
In silico
In vitro
  • -

    Inhibition of cholinoesterases—acetylcholinesterase (AChE), butyrylcholinesterase (BChE)

  • -

    Inhibition of β-secretase 1 (BACE 1)

[60]
female C57 BL/6 mice
  • -

    Antidepressant-like effect

  • -

    Improvement of cognitive performance and spatial memory

  • -

    Antioxidant—increase in antioxidant enzymes activity and glutathione levels

[61]
Male Albino Wistar rats
  • -

    Decrease in AChE activity

  • -

    Improved learning and memory

  • -

    Suppression of APP, β-amyloid, β-, γ-secretases expression

[62]
Male APP/PS1 mice
  • -

    Improvement in learning and memory

  • -

    Anti-inflammatory and anti-oxidant via activation of Akt/Nrf2 and inhibition of RAGE/NF-κB signaling pathways

[63]
In silico
In vitro
  • -

    Anti-amyloidogenic—BACE-1 inhibition

  • -

    Antioxidant

[64]
APPswe/PS1dE9 mice
  • -

    Improvement in learning and memory

  • -

    Amelioration of recognition memory

  • -

    Antioxidant—an increase of antioxidative defense; decrease in GKS-3β activity

[65]
Adult male C57BL/6 mice
  • -

    Amelioration of motor dysfunction

  • -

    Anti-inflammatory—suppression of microglia activation; inhibition of COX-2 and attenuation of inflammatory cytokines—IL-1β, IL-4, IL-6, IL-10, TNF-α release

[66]
Male Wistar rats
  • -

    Anti-apoptotic—a decrease of Bcl-2 and increase of Bax expression

  • -

    Amelioration of learning and memory

  • -

    Antioxidant—increase in glutathione levels; enhancement of antioxidant enzymes activity—SOD, CAT, GPx

[67]
male transgenic APP/PS1–21 mice
  • -

    Decrease in microglial activation

  • -

    Decrease in TGF-1β expression

  • -

    Anti-amyloidogenic—attenuation in β-amyloid depositions accumulation and APP expression

[68]
Swiss male albino mice
  • -

    Attenuation of AChE activity

  • -

    Anti-inflammatory—inhibition of NF-κB pathway and the release of COX-2 and iNOS

  • -

    Inhibition of astrocytes activation

  • -

    Improved memory consolidation

[69]
Hesperetin
adult male mice (C57BL/6N, wild type)
HT22 cells
  • -

    Decrease in oxidative stress (via increase of Nrf2 HO-1 expression)

  • -

    Anti-neuroinflammatory effect (reversion of β-amyloid-induced activation of astrocytes and microglia; decrease in TLR4, NF-κB expression)

  • -

    Anti-apoptotic (downregulation of proapoptotic markers—Bax, Caspase-3, PARP-1; up-regulation of anti-apoptotic marker—Bcl-2)

  • -

    Regulation of synaptic markers—increase in Syntaxin, SNAP-25, PSD-95, Syp, and SNAP-23 levels

  • -

    Alleviation of short-term memory dysfunction

[70]
PC12 cells
  • -

    Antioxidant—induction of PKA, PI-3K, PGC-1α, and seladin-1 via ER- and TrkA-meditated pathways

[71]
Wistar rats
  • -

    Improvement in learning and recognition memory

  • -

    Antioxidant (increase in glutathione and CAT, SOD, GRX, and GPX levels and decrease of lipid peroxidation)

[72]
PC12 cells
  • -

    Decrease in Ca2+ level

  • -

    Antioxidantan increase in CAT, GSH-Px, and GRx levels

  • -

    Decrease in caspase-3 activity

  • -

    Maintenance of mitochondrial membrane potential

  • -

    Decrease in DNA damage

[73]
Neuro-2A cells
  • -

    Inhibition of β-amyloid-induced autophagy

  • -

    Improved glucose utilization

[59]
In silico
In vitro
  • -

    Inhibition of cholinesterases—acetylcholinesterase (AChE), butyrylcholinesterase (BChE)

  • -

    Inhibition of β-secretase 1 (BACE 1)

[60]
ICR female mice
  • -

    Antioxidant—activation of antioxidant enzymes—CAT, SOD

[74]
Male albino Wistar rats
  • -

    Decrease in AChE activity

  • -

    Maintenance of mitochondrial membrane potential

  • -

    Antiapoptotic—decrease in Bax, caspase-3, 9 levels and increase in Bcl2

  • -

    Antioxidant—increase in CAT, SOD, Gpx, GST activity

[75]
Male C57BL/6 N mice
  • -

    Antioxidant—decreased production of ROS and increased antioxidant proteins Nrf2, HO-1 levels

  • -

    Anti-inflammatory—decreased expression of proinflammatory cytokines—TNF-α, IL-1β, p-NF-κB

  • -

    Antiapoptotic—decreased expression of p-JNK, Bax, and caspase-3 increased expression of Bcl-2

  • -

    Enhanced synaptic integrity, cognition, and memory process

[76]
Male adult Wistar rats
PD
  • -

    Improved motor functions

  • -

    Attenuation of apoptosis by increased Bcl2 expression

  • -

    Attenuation of astrogliosis by a decrease in GFAP levels

  • -

    Decreased neuroinflammation by reduction of NF-κB levels

[77]
Cortical cells
  • -

    Inhibition of NMDA-induced excitotoxicity caused by the excess of glutamate

  • -

    Protection against β-amyloid-induced neuronal damage

[78]
C57/BL6 male mice
BV-2 microglial cells
  • -

    Inhibition of astrocyte and microglial activation

  • -

    Anti-inflammatory—attenuation of production of iNOS, NO, IL-6, IL-1β

[79]
SH-SY5Y cells
  • -

    Attenuation of apoptosis—decrease in caspase-3, -9 expression

  • -

    Antioxidant—increased levels of GSH, SOD, and expression of NRF2 and HO-1

[80]
Male albino mice
  • -

    Improved spatial learning and reference memory

  • -

    Maintenance of cholinergic neurotransmission

  • -

    Inhibition of AChE activity

  • -

    Antioxidant—increase in SOD and GSH levels

  • -

    Increased BDNF levels

[81]
RAW 264.7 Cells
  • -

    Anti-inflammatory effect concerning inhibition of NF-κB and activation of Nrf2/HO-1—suppression of proinflammatory cytokines (TNF-α, IL-6, IL1β) and pro-inflammatory enzymes (iNOS, COX-2) expression

[82]